Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2012
08/14/2012US8241670 Compositions capable of facilitating penetration across a biological barrier
08/14/2012US8241669 Endoparasiticidal gel composition
08/14/2012US8241668 Polymers contqining ester, thioester or amide groups in backbone which degrade into bioactive material upon hydrolysis
08/14/2012US8241665 Chewable soft capsule
08/14/2012US8241663 Liposome preparation
08/14/2012US8241662 Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy
08/14/2012US8241660 Patch for the expulsion of insect poison from the skin after stings from membranous insects (hymenoptera)
08/14/2012US8241659 Nutrition with lipids and non-digestible saccharides
08/14/2012US8241658 Prebiotic compositions
08/14/2012US8241640 Pharmaceutical botulinum toxin compositions
08/14/2012US8241609 Method for embolization using liquid embolic materials
08/14/2012US8241416 Inorganic waterborne coating agent and its aqueous solution
08/14/2012CA2658434C Improvement of the bioavailability of active substances having an amidine function in medicaments
08/14/2012CA2632078C Methods of inducing terminal differentiation
08/14/2012CA2553619C Biodegradable multi-block co-polymers
08/14/2012CA2524979C Solid dosage form comprising (s)-pantoprazole magnesium salt
08/14/2012CA2523079C Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
08/14/2012CA2501821C Bispecific anti-erb-b antibodies and their use in tumor therapy
08/14/2012CA2498233C Clear ophthalmic solution comprising latanoprost as active ingredient
08/14/2012CA2497845C Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
08/14/2012CA2494568C Patches containing tulobuterol
08/14/2012CA2469028C Pharmaceutical composition in the form of gel or solution based on dihydrotestosterone, preparation method and uses thereof
08/14/2012CA2452075C Sustained release delivery system
08/14/2012CA2451187C Zero-order prolonged release coaxial implants
08/14/2012CA2446622C Isostearic acid salts as permeation enhancers
08/14/2012CA2436326C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
08/14/2012CA2332455C Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
08/14/2012CA2218166C Methods of inducing immune tolerance using immunotoxins
08/09/2012WO2012106713A2 Targeted nanoparticle conjugates
08/09/2012WO2012106317A1 Injectable thermoresponsive polyelectrolytes
08/09/2012WO2012106299A1 Pharmaceutical compositions of cytidine analogs and methods of use thereof
08/09/2012WO2012106281A2 Multimodal trail molecules and uses in cellular therapies
08/09/2012WO2012106118A2 Method of making ophthalmic devices and components thereof from hydrophobic acrylic (ha) polymers with reduced or eliminated glistenings
08/09/2012WO2012105887A1 Active principle for mitigating undesired medical conditions
08/09/2012WO2012105797A2 Structure having nanoantenna and method for manufacturing same
08/09/2012WO2012105794A2 Magnetic nanoparticle, having a curie temperature which is within biocompatible temperature range, and method for preparing same
08/09/2012WO2012105715A1 Novel external preparation
08/09/2012WO2012105625A1 Transdermal absorption-promoting agent and transdermal patch containing same
08/09/2012WO2012105624A1 Transdermal patch
08/09/2012WO2012105623A1 Production method for adhesive patch
08/09/2012WO2012105622A1 Patch preparation
08/09/2012WO2012105621A1 Production method for adhesive patch
08/09/2012WO2012105620A1 Patch and patch preparation
08/09/2012WO2012105619A1 Patch and patch preparation
08/09/2012WO2012105618A1 Patch preparation
08/09/2012WO2012105595A1 Drug delivery material capable of passing through blood-brain barrier, and peptide and use thereof
08/09/2012WO2012105551A1 Water-soluble preparation containing physiologically active substance and process for production thereof
08/09/2012WO2012105546A1 Process for producing aqueous solution containing fat-soluble substance
08/09/2012WO2012105521A1 Externally-used drug for treating skin disorder and method for producing same
08/09/2012WO2012105485A1 Dermal composition comprising polymeric reversed micelle, and method for producing same
08/09/2012WO2012105467A1 Oligonucleic acid composition and antiallergic agent
08/09/2012WO2012105224A1 Vaccine adjuvant
08/09/2012WO2012105223A1 Immunity activation drug
08/09/2012WO2012105219A1 Antibody therapy effect-enhancing drug
08/09/2012WO2012104730A1 Pharmaceutical preparation
08/09/2012WO2012104654A1 Compositions and methods for treating cardiovascular diseases
08/09/2012WO2012104638A1 Therapeutic agents with improved fibrinogen binding
08/09/2012WO2012104464A1 Semi-solid bioadhesive system for the administration of active substance
08/09/2012WO2012104461A1 Development and use of polymer nanoparticles comprising poly(epsilon-caprolactone) and doxorubicin
08/09/2012WO2012104419A1 Hyaluronic acid composition
08/09/2012WO2012104344A1 Human antibodies and antibody-drug conjugates against cd74
08/09/2012WO2012103802A1 Liquid medicinal composition containing echinocandin antifungal agent micafungin
08/09/2012WO2012103801A1 Medicinal composition containing echinocandin antifungal agent micafungin, and preparation method and use therefor
08/09/2012WO2012103634A1 Cellulose-based nanoparticles for drug delivery
08/09/2012WO2012080836A3 Functionalized polymers
08/09/2012WO2012080176A3 Pharmaceutical compositions comprising alisporivir
08/09/2012WO2012071389A3 Stable cannabinoid compositions and methods for making and storing them
08/09/2012WO2012054500A3 Compositions for drug administration
08/09/2012WO2012049527A3 Method for purifying diatomaceous earth suitable for pharmaceutical use
08/09/2012WO2012039960A3 Material for medical use comprising nanoparticles with superparamagnetic properties and its utilization in surgery
08/09/2012WO2011115684A3 Lipid vesicle compositions and methods of use
08/09/2012US20120203307 Method and device for treating abnormal tissue growth with electrical therapy
08/09/2012US20120202896 Composition including a copolyamide and a cross-linked polyolefin
08/09/2012US20120202894 Rapidly Soluble Solid Pharmaceutical Preparations Containing Amphiphilic Copolymers Based On Polyethers In Combination With Hydrophilic Polymers
08/09/2012US20120202890 Polymer-carbohydrate-lipid conjugates
08/09/2012US20120202880 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
08/09/2012US20120202879 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
08/09/2012US20120202871 Cationic lipids and methods for the delivery of therapeutic agents
08/09/2012US20120202841 Topical Compositions Comprising Ascomycins
08/09/2012US20120202839 Methods and compositions for deterring abuse of orally administered pharmaceutical products
08/09/2012US20120202780 Carrier composition
08/09/2012US20120202735 Antimicrobial cationic peptides and formulations thereof
08/09/2012US20120201901 Topical Antibiotic Formulations
08/09/2012US20120201891 Transdermal delivery patch
08/09/2012US20120201871 Permeation enhancers with liposomes for topical formulations
08/09/2012US20120201858 Multiple-arm peptide compounds, methods of manufacture and use in therapy
08/09/2012US20120201849 Vaccine stabilizer
08/09/2012US20120201843 Cyp1b1 nucleic acids and methods of use
08/09/2012US20120201841 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201806 Liquid-retaining elastomeric compositions
08/09/2012US20120201800 Methods and Devices for Sustained In-Vivo Release Of an Active Agent
08/09/2012US20120201763 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
08/09/2012US20120201748 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
08/09/2012CA2857944A1 Injectable thermoresponsive polyelectrolytes
08/09/2012CA2826513A1 Pharmaceutical preparation
08/09/2012CA2826506A1 Compositions and methods for treating chronic inflammation and inflammatory diseases
08/09/2012CA2826452A1 Compositions and methods for treating cardiovascular diseases
08/09/2012CA2826362A1 Patch and patch preparation
08/09/2012CA2826218A1 Patch and patch preparation
1 ... 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 ... 1712